Jack Higgins - 10 Sep 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Scientific Officer
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
10 Sep 2025
Net transactions value
+$29,700
Form type
4
Filing time
11 Sep 2025, 21:04:17 UTC
Previous filing
31 Jul 2025
Next filing
22 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Higgins Jack Chief Scientific Officer C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL /s/ Sandra Stoneman, Attorney-in-Fact 11 Sep 2025 0001993684

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Options Exercise $29,700 +22,000 +117% $1.35 40,729 10 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Employee Stock option (right to buy) Options Exercise $0 -22,000 -13% $0.000000 151,840 10 Sep 2025 Common Stock 22,000 $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.